MSB 1.02% 97.0¢ mesoblast limited

The ongoing trial is not considered futile it's meeting the...

  1. 1,300 Posts.
    lightbulb Created with Sketch. 6
    The ongoing trial is not considered futile it's meeting the predicted end point and benefiting patients. The alternative concept is that it's futile to resist, either way, MSB shareholders and CHF patients win. The US will be interesting tonight MSB is building a strong body of evidence demonstrating proof of concept resistance is futile.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
97.0¢
Change
-0.010(1.02%)
Mkt cap ! $1.107B
Open High Low Value Volume
98.0¢ 98.5¢ 95.5¢ $6.248M 6.438M

Buyers (Bids)

No. Vol. Price($)
1 10000 96.5¢
 

Sellers (Offers)

Price($) Vol. No.
97.0¢ 116040 7
View Market Depth
Last trade - 16.10pm 26/06/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.